Article info

Download PDFPDF
Extended report
Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

Authors

  1. Correspondence to
    Professor Marjatta Leirisalo-Repo, Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital, P O Box 440, Helsinki FI-00029 HUS, Finland; marjatta.leirisalo-repo{at}hus.fi
View Full Text

Citation

Leirisalo-Repo M, Kautiainen H, Laasonen L, et al
Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

Publication history

  • Received January 17, 2012
  • Accepted May 31, 2012
  • First published June 30, 2012.
Online issue publication 
May 10, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.